These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
647 related items for PubMed ID: 9717542
1. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium]. Finazzo M, Midiri M, Gallo C, Bartolotta TV, Luca A. Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542 [Abstract] [Full Text] [Related]
2. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media]. Bartolotta TV, Midiri M, Galia M, Carcione A, De Maria M, Lagalla R. Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050 [Abstract] [Full Text] [Related]
3. [Superparamagnetic iron oxide in the differential diagnosis of focal hepatic lesions using a 0.5-tesla magnetic resonance apparatus]. Di Cesare E, Cariello G, Marchese F, Michelini O, Costanzi A, Catalucci A, Splendiani A, Masciocchi C. Radiol Med; 1998 Jun; 95(6):593-8. PubMed ID: 9717541 [Abstract] [Full Text] [Related]
4. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media]. Di Cesare E, Cariello G, Barile A, Sabatini M, Michelini O, Erriquez D, Masciocchi C. Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451 [Abstract] [Full Text] [Related]
5. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography. Tanimoto A, Wakabayashi G, Shinmoto H, Nakatsuka S, Okuda S, Kuribayashi S. J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974 [Abstract] [Full Text] [Related]
6. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media]. Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D. Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882 [Abstract] [Full Text] [Related]
7. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. Grandin C, Van Beers BE, Robert A, Gigot JF, Geubel A, Pringot J. J Comput Assist Tomogr; 1995 Sep; 19(3):412-8. PubMed ID: 7790551 [Abstract] [Full Text] [Related]
8. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem]. Vogl TJ, Hammerstingl R, Keck H, Felix R. Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032 [Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, Wyatt JI, Robinson PJ. Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242 [Abstract] [Full Text] [Related]
10. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. Kumano S, Murakami T, Kim T, Hori M, Okada A, Sugiura T, Noguchi Y, Kawata S, Tomoda K, Nakamura H. AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430 [Abstract] [Full Text] [Related]
11. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging. Halavaara JT, Lamminen AE, Bondestam S, Standertskjöld-Nordenstam CG, Hamberg LM. J Comput Assist Tomogr; 1994 Nov; 18(6):897-904. PubMed ID: 7962796 [Abstract] [Full Text] [Related]
12. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. Winter TC, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas CR, Elliott S. AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724 [Abstract] [Full Text] [Related]
13. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]. Stroszczynski C, Gaffke G, Gretschel S, Rambow A, Jost D, Schlecht I, Schneider U, Schicke B, Hohenberger P, Gebauer B, Felix R. Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106 [Abstract] [Full Text] [Related]
14. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI. J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184 [Abstract] [Full Text] [Related]
15. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats]. Liu X, Xu YK, Huang QL, Wu YK. Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574 [Abstract] [Full Text] [Related]
17. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. Coenegrachts K, Orlent H, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H. J Magn Reson Imaging; 2008 Jan; 27(1):117-24. PubMed ID: 18050350 [Abstract] [Full Text] [Related]
18. Specificity of SPIO particles for characterization of liver hemangiomas using MRI. Montet X, Lazeyras F, Howarth N, Mentha G, Rubbia-Brandt L, Becker CD, Vallee JP, Terrier F. Abdom Imaging; 2004 Jan; 29(1):60-70. PubMed ID: 15160755 [Abstract] [Full Text] [Related]
19. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity. Tanabe M, Ito K, Shimizu A, Fujita T, Onoda H, Yamatogi S, Washida Y, Matsunaga N. Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487 [Abstract] [Full Text] [Related]
20. Focal eosinophilic necrosis on superparamagnetic iron oxide-enhanced MRI. Cho ES, Yu JS, Kim MJ, Kim JH, Chung JJ, Kim KW. AJR Am J Roentgenol; 2010 May; 194(5):1296-302. PubMed ID: 20410417 [Abstract] [Full Text] [Related] Page: [Next] [New Search]